ArticleJournal of gastrointestinal oncology2024

Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study.

Can Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.